Tech stocks: Varian acquisition pushes up Agilent earnings

Agilent Technologies Inc., symbol A on New York, makes testing systems that improve electronic products, such as cellphones and networking equipment. In May 2010, Agilent bought Varian Inc. for $1.5 billion. Varian makes a wide range of medical and drug-testing equipment, such as mass spectrometers that detect and measure substances in the blood and other samples. Medical-equipment demand is less cyclical than testing products, so this move cuts the tech stock’s risk. Thanks to Varian, Agilent earned $200.0 million, or $0.56 a share, in the three months ended April 30, 2011. That’s up 85.2% from $108.0 million, or $0.31 a share, a year earlier. These figures include restructuring costs and expenses related to integrating Varian. The tech stock’s revenue jumped 31.9%, to $1.7 billion from $1.3 billion. The company spends around 10% of its revenue on research and development. Agilent holds cash of $3.0 billion, or $8.55 a share. The tech stock’s $2.1 billion of long-term debt is only 12% of its $17.1-billion market cap. You can get our in-depth analysis, including our updated buy/sell/hold advice, on Agilent and other U.S. companies (including tech stocks) when you subscribe to Wall Street Stock Forecaster. What’s more, you can get one month free when you subscribe today. Click here to learn how.

Jim is an associate editor at TSI Network. He is the lead reporter and analyst for The Successful Investor and Wall Street Stock Forecaster and a member of the Investment Planning Committee. Jim has held the Chartered Financial Analyst designation since 1992 and spent more than a decade at the Financial Post DataGroup before joining TSI Network. He has a Bachelor of Commerce degree from the University of Toronto.